Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

12.21

+1.99 (19.47%)

Aug 28, 2025, 4:00 PM - Market closed

Neuphoria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 28, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Debt / Equity Ratio	0.01	0.01	0.02	0.01	0.02	0.97	Upgrade
Debt / EBITDA Ratio	1.63	-	-	-	-	-	Upgrade
Debt / FCF Ratio	0.27	-	-	-	-	-	Upgrade
Asset Turnover	-	-	-	0.10	0.02	0.07	Upgrade
Quick Ratio	11.00	3.33	4.58	12.02	12.55	0.91	Upgrade
Current Ratio	11.01	3.45	4.87	12.46	13.10	1.01	Upgrade
Return on Equity (ROE)	25.45%	-78.44%	-71.40%	-41.64%	-28.86%	-39.88%	Upgrade
Return on Assets (ROA)	-	-39.58%	-37.41%	-18.40%	-14.48%	-10.62%	Upgrade
Return on Capital (ROIC)	-1.25%	-55.48%	-44.40%	-20.74%	-17.50%	-15.67%	Upgrade
Buyback Yield / Dilution	-352.55%	-22.39%	-8.53%	-73.52%	-43.14%	-4.52%	Upgrade

Updated May 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q